Skip to main content
. Author manuscript; available in PMC: 2019 Jul 30.
Published in final edited form as: Schizophr Res. 2018 Feb 12;197:321–327. doi: 10.1016/j.schres.2018.01.018

Table 3.

Between groups differences in mRNA expression and association with clinical characteristics.

Variable C4A STAT1 IRF-1

F p df F p df F p df
Between Groups 0.91 .40 2, 127 1.2 .31 2, 126 4.6 .01 2, 125
Expression r2 p n r2 p n r2 p n
 STAT1 .21 .02 129
 IRF-1 .29 .001 128 .53 .00 128
PANSS r2 p n r2 p n r2 p n
 Positive .31 .004 86 −.11 .3 85 .18 .10 84
  Delusions .31 .003 86
   SCZ .26 .04 64
   BD-P .43 .04 23
 Negative .14 .20 86 −.03 .82 85 .12 .29 84
 Cognitive .11 .30 86 −.18 .10 85 .09 .44 84
 Excitement −.06 .61 86 −.09 .39 85 .10 .36 84
 Depression .19 .08 86 −.02 .87 85 .17 .12 84
PSYRATS Delusions r2 p n r2 p n r2 p n
 SCZ .35 .03 39
 BD-P −.37 .17 15